申请人:Schering AG
公开号:US20040009969A1
公开(公告)日:2004-01-15
This invention relates to new piperazine derivatives of general formula I,
1
in which V, W, n, R, R′, i, j, Y and Z have the meaning that is indicated in the description.
The compounds according to the invention are distinguished by a diazacycloalkane substituent. They have at their disposal a special action with respect to the action that destabilizes the androgen receptor and can be used, for example, for treating prostate cancer.
这项发明涉及一般式I的新哌嗪衍生物,
其中V、W、n、R、R′、i、j、Y和Z的含义如描述中所示。
根据该发明的化合物具有一种二氮杂环戊烷取代基。它们具有一种特殊作用,可以对破坏雄激素受体的作用产生特殊影响,例如可用于治疗前列腺癌。